机构:[1]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China广东省中医院[2]Guangzhou Univ Chinese Med, Postdoctoral Programme, Guangzhou, Peoples R China[3]Guangdong Prov Hosp Chinese Med, Guangzhou, Peoples R China广东省中医院[4]Guangdong Prov Acad Chinese Med Sci, Guangzhou, Peoples R China广东省中医院[5]Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou, Peoples R China广东省中医院[6]Chinese Univ Hong Kong, Sch Biomed Sci, Key Lab Regenerat Med, Minist Educ,Fac Med, Hong Kong, Peoples R China[7]Chinese Acad Sci Chinese Univ Hong Kong Joint Lab, Kunming Inst Zool, Hong Kong, Peoples R China
第一作者机构:[1]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China[2]Guangzhou Univ Chinese Med, Postdoctoral Programme, Guangzhou, Peoples R China[3]Guangdong Prov Hosp Chinese Med, Guangzhou, Peoples R China[4]Guangdong Prov Acad Chinese Med Sci, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
Chen Haiming,Liu Huazhen,Lu Chuanjian,et al.PSORI-CM02 Formula Increases CD4+ Foxp3+ Regulatory T Cell Frequency and Ameliorates Imiquimod-Induced Psoriasis in Mice (vol 8, 1767, 2018)[J].FRONTIERS IN IMMUNOLOGY.2020,11:doi:10.3389/fimmu.2020.01650.
APA:
Chen, Haiming,Liu, Huazhen,Lu, Chuanjian,Wang, Maojie,Li, Xiong...&Dai, Zhenhua.(2020).PSORI-CM02 Formula Increases CD4+ Foxp3+ Regulatory T Cell Frequency and Ameliorates Imiquimod-Induced Psoriasis in Mice (vol 8, 1767, 2018).FRONTIERS IN IMMUNOLOGY,11,
MLA:
Chen, Haiming,et al."PSORI-CM02 Formula Increases CD4+ Foxp3+ Regulatory T Cell Frequency and Ameliorates Imiquimod-Induced Psoriasis in Mice (vol 8, 1767, 2018)".FRONTIERS IN IMMUNOLOGY 11.(2020)